Home › Niet-kleincellige longkanker › Californië › Mountain View
Niet-kleincellige longkanker klinische studies in Mountain View, CA
21 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Mountain View (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
RekruterenFase 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mijl verwijderd
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mijl verwijderd
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mijl verwijderd
Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLC
RekruterenFase 3
- Stanford University, Stanford · 5 mijl verwijderd
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
RekruterenFase 2
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruterenObservatieonderzoek
- Stanford University, Palo Alto · 5 mijl verwijderd
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
RekruterenFase 2
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
- Stanford Hospital and Clinics, Stanford · 5 mijl verwijderd
- Stanford Hospital Investigational Drug Services, Stanford · 5 mijl verwijderd
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruterenFase 3
- Stanford Cancer Center, Palo Alto · 5 mijl verwijderd
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
RekruterenFase 1/2
- Stanford University Medical Center - Neurology, Stanford · 5 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruterenFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mijl verwijderd
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
RekruterenFase 1/2
- Stanford Cancer Institute, Stanford · 5 mijl verwijderd
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
RekruterenFase 1/2
- Stanford University Medical Center, Stanford · 5 mijl verwijderd
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RekruterenFase 1
- Stanford University Medical Center, Palo Alto · 5 mijl verwijderd
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekruterenFase 1
- Stanford University, Palo Alto · 5 mijl verwijderd
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekruterenFase 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mijl verwijderd
A Study of LY4175408 in Participants With Advanced Cancer
RekruterenFase 1
- Stanford Medicine Cancer Center, Stanford · 5 mijl verwijderd
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruterenFase 1/2
- Stanford University, Stanford · 5 mijl verwijderd
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RekruterenFase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mijl verwijderd
Engagement of Veterans With Lung Cancer
Rekruteren
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mijl verwijderd
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Stanford · 5 mijl verwijderd
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RekruterenFase 1
- Stanford University, Stanford · 5 mijl verwijderd
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in Mountain View
- Kanker (alle vormen)40 studies
- Borstkanker26 studies
- Metastatische kanker25 studies
- Acute myeloïde leukemie19 studies
- Eierstokkanker19 studies
- Autismespectrumstoornis17 studies
- Longkanker17 studies
- Prostaatkanker15 studies
- Hartfalen15 studies
- Autisme13 studies
- Acute lymfoblastaire leukemie13 studies
- Colorectale kanker13 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.